(PREDICT) A Multi-Center Study in Patients Undergoing Anthracycline-Based Chemotherapy to Assess the Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: biological markers | anthracyclines | cardiotoxins
Age: Between 1 - 99 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required